Online Program

Return to main conference page
Thursday, September 13
Thu, Sep 13, 4:15 PM - 5:30 PM
Thurgood Marshall North
New Perspective of Composite Endpoints in Drug Development

Composite Endpoints in Cardio-Renal Clinical Outcome Trials (300663)

*Hsien Ming J Hung, FDA 

Keywords: composite endpoint, event type, recurrent events

This talk is intended to share my perspective on composite endpoints and related issues in clinical outcome trials for cardiovascular and renal diseases. The following subjects are to be covered: 1. Formation of composite endpoints, multiple events, recurrent events 2. First occurrence and multiple recurrences 3. Metrics for treatment effect 4. Statistical inference and description of treatment effect